These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34445354)

  • 1. Targeted and Non-Targeted Mechanisms for Killing Hypoxic Tumour Cells-Are There New Avenues for Treatment?
    Apilan AG; Mothersill C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy.
    Mistry IN; Thomas M; Calder EDD; Conway SJ; Hammond EM
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1183-1196. PubMed ID: 28721903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy.
    Hua L; Wang Z; Zhao L; Mao H; Wang G; Zhang K; Liu X; Wu D; Zheng Y; Lu J; Yu R; Liu H
    Theranostics; 2018; 8(18):5088-5105. PubMed ID: 30429888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Hypoxia: Revival of Old Remedies.
    Vilaplana-Lopera N; Besh M; Moon EJ
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical radiosensitizers for use in radiotherapy.
    Wardman P
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies.
    Bache M; Kappler M; Said HM; Staab A; Vordermark D
    Curr Med Chem; 2008; 15(4):322-38. PubMed ID: 18288988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in radiosensitization.
    Linam J; Yang LX
    Anticancer Res; 2015 May; 35(5):2479-85. PubMed ID: 25964520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumors with hypoxia-activated cytotoxins.
    Ahn GO; Brown M
    Front Biosci; 2007 May; 12():3483-501. PubMed ID: 17485316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring hypoxic biology to improve radiotherapy outcomes.
    Li C; Wiseman L; Okoh E; Lind M; Roy R; Beavis AW; Pires IM
    Expert Rev Mol Med; 2022 Apr; 24():e21. PubMed ID: 35586915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New radiosensitizing regimens, drugs, prodrugs, and candidates.
    Vallerga AK; Zarling DA; Kinsella TJ
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy.
    Ghattass K; Assah R; El-Sabban M; Gali-Muhtasib H
    Curr Cancer Drug Targets; 2013 Jul; 13(6):670-85. PubMed ID: 23687923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.
    Weinmann M; Welz S; Bamberg M
    Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):364-74. PubMed ID: 12871083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
    Horsman MR
    Acta Oncol; 1995; 34(5):571-87. PubMed ID: 7546822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and its therapeutic possibilities in paediatric cancers.
    Bernauer C; Man YKS; Chisholm JC; Lepicard EY; Robinson SP; Shipley JM
    Br J Cancer; 2021 Feb; 124(3):539-551. PubMed ID: 33106581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to combat hypoxia in cancer therapy and the potential for in silico models in their evaluation.
    Forster JC; Marcu LG; Bezak E
    Phys Med; 2019 Aug; 64():145-156. PubMed ID: 31515013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of hypoxia-targeting drugs as new cancer chemotherapeutics.
    Nagasawa H; Uto Y; Kirk KL; Hori H
    Biol Pharm Bull; 2006 Dec; 29(12):2335-42. PubMed ID: 17142959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic sensitizer and cytotoxin for head and neck cancer.
    Lee DJ; Moini M; Giuliano J; Westra WH
    Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modifiers of cancer treatment.
    Coleman CN; Bump EA; Kramer RA
    J Clin Oncol; 1988 Apr; 6(4):709-33. PubMed ID: 3282035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Oxygen effect: an old new target?].
    Lartigau E; Dewas S; Gras L
    Cancer Radiother; 2008 Jan; 12(1):42-9. PubMed ID: 18261946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia: targeting the tumour.
    Boyle RG; Travers S
    Anticancer Agents Med Chem; 2006 Jul; 6(4):281-6. PubMed ID: 16842231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.